Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs
Since the approval of modifying therapies for Spinal Muscular Atrophy (SMA), several protocols aiming to screen <i>SMN1</i> homozygous deletion in a neonatal context have been published. However, no work has compared different methodologies along with detailed implementation costs for ce...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/7/3/53 |